Skip to content

Taking a Look at Patient Experiences In Rectal Cancer Clinical Trials

Investigating Medical Research Trends in Rectal Cancer Clinical Study: Analyzing Factors Impacting Patient Involvement

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05910099
Enrollment
500
Registered
2023-06-18
Start date
2024-07-31
Completion date
2026-07-31
Last updated
2023-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

Rectal Cancer

Brief summary

The primary objective of this research study is to explore the barriers encountered by specific demographic groups of rectal cancer patients during the engagement in clinical trials, which historically lack diverse representation. By carefully analyzing data from various demographic perspectives, this study aims to uncover patterns that impact the experiences of future rectal cancer patients. Active involvement in this crucial research is of utmost importance, as it can offer unique insights to enhance the participation and completion rates of rectal cancer patients in clinical study.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Confirmed diagnosis of rectal cancer * Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed * No prior treatment for rectal cancer

Exclusion criteria

* Pregnant or lactating woman * Inability to provide written informed consent * Enrolled in another research study

Design outcomes

Primary

MeasureTime frame
Number of rectal cancer patients who decide to participate in a clinical study3 months
Rate of patients who remain in a rectal cancer clinical study to completion12 months

Countries

United States

Contacts

Primary ContactMichael B Gill
bask@withpower.com4159004227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026